JANUS-ASSOCIATED KINASE (JAK) INHIBITORS (L01EJ)
- fedratinib (fedratinib hydrochloride) (INREBIC)
- momelotinib (momelotinib dihydrochloride) (OJJAARA)
- ruxolitinib (ruxolitinib phosphate) (JAKAVI)
Using Health Canada Drug Database
updated on 14Sep2025.